Phase II study of IPI 940 in patients with pain

Trial Profile

Phase II study of IPI 940 in patients with pain

Planning
Phase of Trial: Phase II

Latest Information Update: 10 Jan 2011

At a glance

  • Drugs IPI 940 (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Sponsors Purdue Pharma
  • Most Recent Events

    • 10 Jan 2011 New trial record
    • 07 Jan 2011 Infinity Pharmaceuticals expect to complete transition activities to facilitate phase II studies in pain by Purdue Pharmaceuticals, according to an Infinity media release
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top